Cargando…

Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy

To gain insights into neutrophil heterogeneity dynamics in the context of sterile inflammation and wound healing, we performed a pseudotime analysis of single-cell flow cytometry data using the spanning-tree progression analysis of density-normalized events algorithm. This enables us to view neutrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, T. C., Sok, M. C. P., Hymel, L. A., Pittman, F. S., York, W. Y., Mac, Q. D., Vyshnya, S., Lim, H. S., Kwong, G. A., Qiu, P., Botchwey, E. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608810/
https://www.ncbi.nlm.nih.gov/pubmed/33127670
http://dx.doi.org/10.1126/sciadv.aba7702
_version_ 1783604905628401664
author Turner, T. C.
Sok, M. C. P.
Hymel, L. A.
Pittman, F. S.
York, W. Y.
Mac, Q. D.
Vyshnya, S.
Lim, H. S.
Kwong, G. A.
Qiu, P.
Botchwey, E. A.
author_facet Turner, T. C.
Sok, M. C. P.
Hymel, L. A.
Pittman, F. S.
York, W. Y.
Mac, Q. D.
Vyshnya, S.
Lim, H. S.
Kwong, G. A.
Qiu, P.
Botchwey, E. A.
author_sort Turner, T. C.
collection PubMed
description To gain insights into neutrophil heterogeneity dynamics in the context of sterile inflammation and wound healing, we performed a pseudotime analysis of single-cell flow cytometry data using the spanning-tree progression analysis of density-normalized events algorithm. This enables us to view neutrophil transitional subsets along a pseudotime trajectory and identify distinct VEGFR1, VEGFR2, and CXCR4 high-expressing pro-angiogenic neutrophils. While the proresolving lipid mediator aspirin-triggered resolvin D1 (AT-RvD1) has a known ability to limit neutrophil infiltration, our analysis uncovers a mode of action in which AT-RvD1 leads to inflammation resolution through the selective reprogramming toward a therapeutic neutrophil subset. This accumulation leads to enhanced vascular remodeling in the skinfold window chamber and a proregenerative shift in macrophage and dendritic cell phenotype, resulting in improved wound closure after skin transplantation. As the targeting of functional immune subsets becomes the key to regenerative immunotherapies, single-cell pseudotime analysis tools will be vital in this field.
format Online
Article
Text
id pubmed-7608810
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-76088102020-11-13 Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy Turner, T. C. Sok, M. C. P. Hymel, L. A. Pittman, F. S. York, W. Y. Mac, Q. D. Vyshnya, S. Lim, H. S. Kwong, G. A. Qiu, P. Botchwey, E. A. Sci Adv Research Articles To gain insights into neutrophil heterogeneity dynamics in the context of sterile inflammation and wound healing, we performed a pseudotime analysis of single-cell flow cytometry data using the spanning-tree progression analysis of density-normalized events algorithm. This enables us to view neutrophil transitional subsets along a pseudotime trajectory and identify distinct VEGFR1, VEGFR2, and CXCR4 high-expressing pro-angiogenic neutrophils. While the proresolving lipid mediator aspirin-triggered resolvin D1 (AT-RvD1) has a known ability to limit neutrophil infiltration, our analysis uncovers a mode of action in which AT-RvD1 leads to inflammation resolution through the selective reprogramming toward a therapeutic neutrophil subset. This accumulation leads to enhanced vascular remodeling in the skinfold window chamber and a proregenerative shift in macrophage and dendritic cell phenotype, resulting in improved wound closure after skin transplantation. As the targeting of functional immune subsets becomes the key to regenerative immunotherapies, single-cell pseudotime analysis tools will be vital in this field. American Association for the Advancement of Science 2020-10-30 /pmc/articles/PMC7608810/ /pubmed/33127670 http://dx.doi.org/10.1126/sciadv.aba7702 Text en Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Research Articles
Turner, T. C.
Sok, M. C. P.
Hymel, L. A.
Pittman, F. S.
York, W. Y.
Mac, Q. D.
Vyshnya, S.
Lim, H. S.
Kwong, G. A.
Qiu, P.
Botchwey, E. A.
Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy
title Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy
title_full Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy
title_fullStr Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy
title_full_unstemmed Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy
title_short Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy
title_sort harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608810/
https://www.ncbi.nlm.nih.gov/pubmed/33127670
http://dx.doi.org/10.1126/sciadv.aba7702
work_keys_str_mv AT turnertc harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT sokmcp harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT hymella harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT pittmanfs harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT yorkwy harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT macqd harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT vyshnyas harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT limhs harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT kwongga harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT qiup harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy
AT botchweyea harnessinglipidsignalingpathwaystotargetspecializedproangiogenicneutrophilsubsetsforregenerativeimmunotherapy